Trade Summary

2 months ago, Sr One Capital Management, LLC, serving as 10% owner at Zenas Biopharma, Inc. (ZBIO), purchased 126,315 shares at $19.00 per share, for a total transaction value of $2,399,985.00. Following this transaction, Sr One Capital Management, LLC now holds 5,037,854 shares of ZBIO.

This purchase represents a 3.00% increase in Sr One Capital Management, LLC's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, October 9, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, October 14, 2025, 5 days after the trade was made.

Zenas Biopharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.